Using functional haemostasis assays, we demonstrated important differences in stability of direct oral anticoagulants (DOACs) in citrated whole blood and plasma from DOAC treated patients. Laboratories and clinicians should take this into consideration and adjust clinical practices accordingly.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.thromres.2016.10.023 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!